Skip to main content
. 2023 Apr 17. Online ahead of print. doi: 10.1016/j.eimce.2022.01.007

Table 2A.

Analytical evaluation of discrepant results (n = 49).

Case TMA Procleix
RT-PCR Allplex™
Type of
disagreement
RT-PCR Alinity m
Analytical
result
Ratioa Ct
Result Ctc
Result N Result E RdRP N RdRP & N
1 P 4.18 N NA NA NA Major N NA N
2 N NA P NA NA 37.59 Major NDd ND
3 P 3.92 N NA NA NA Major P 40.99 P
4 P 3.81 N NA NA NA Major P 39.53 P
5 P 3.81 Ib 37.96 NA NA Minor P 40.94 P
6 P 4.00 N NA NA NA Major N NA N
7 P 4.24 N NA NA NA Major N NA N
8 P 4.24 Ib 38.02 NA NA Minor P 40.03 P
9 P 4.18 N NA NA NA Major NDd ND
10 P 4.20 Ib 36.91 NA NA Minor NDd ND
11 P 3.73 N NA NA NA Major N NA N
12 P 4.15 N NA NA NA Major P 40.90 P
13 P 4.36 N NA NA NA Major P 39.60 P
14 P 4.21 N NA NA NA Major P 37.21 P
15 P 4.16 N NA NA NA Major P 40.90 P
16 P 4.05 Ib 37.88 NA NA Minor NDd ND
17 N NA P NA NA 37.63 Major NDd ND
18 P 4.21 N NA NA NA Major N NA N
19 P 4.23 Ib 38.06 NA NA Minor P 40.99 P
20 P 4.50 N NA NA NA Major P 40.99 P
21 P 4.46 N NA NA NA Major N NA N
22 P 3.95 N NA NA NA Major N NA N
23 P 3.97 N NA NA NA Major N NA N
24 P 4.00 N NA NA NA Major N NA N
25 P 4.12 I 38.23 NA NA Minor P 40.99 P
Case TMA
Procleix SARS-CoV-2
RT-PCR
Allplex™ SARS-CoV-2
Type of disagreement RT-PCR cobas® SARS-CoV-2
Analytical result
Result Ratioa Result Ct
Result Ct
N E RdRP N ORF-1ab E
26 P 4.17 N NA NA NA Major N NA NA N
27 P 3.78 N NA NA NA Major Ib NA 35.63 Ib
28 P 3.84 N NA NA NA Major Ib NA 37.73 Ib
29 P 4.16 N NA NA NA Major N NA NA N
30 P 3.93 N NA NA NA Major P 32.4 34.98 P
31 P 3.90 N NA NA NA Major N NA NA N
32 P 4.22 N NA NA NA Major Ib NA 38.47 Ib
33 P 4.02 N NA NA NA Major N NA NA N
34 P 3.95 N NA NA NA Major N NA NA N
35 P 4.28 N NA NA NA Major P 36.19 37.22 P
36 P 3.92 Ib 36.58 NA NA Minor P 33.15 35.01 P
37 P 4.05 N NA NA NA Major N NA NA N
38 P 4.59 Ib 38.15 NA NA Minor P 33.35 34.51 P
39 P 4.03 N NA NA NA Major N NA NA N
40 P 4.25 N NA NA NA Major Ib NA 38.01 Ib
41 P 4.22 N NA NA NA Major P 35.58 35.87 P
42 P 3.99 N NA NA NA Major N NA NA N
43 P 3.84 N NA NA NA Major N NA NA N
44 P 4.04 Ib 38.18 NA NA Minor N NA NA Ib
45 P 4.46 Ib 38.26 NA NA Minor N NA NA Ib
46 P 4.04 N NA NA NA Major Ib NA 37.94 Ib
47 P 4.35 N NA NA NA Major P 30.80 31.60 P
48 P 4.15 Ib 38.14 NA NA Minor N NA NA Ib
49 P 4.33 N NA NA NA Major N NA NA N
a

The ratio provided by the instrument corresponds to an analytical parameter based on chemiluminescense with a qualitative interpretation. Values ≥1.00 are considered reactive/positive, according to the manufacturer's criteria.

b

Inconclusive cases are considered: (i) those testing positive for the E target, but negative for both the N and the RdRP/S targets with the RT-PCR Allplex™ SARS-CoV-2 assay, according to the manufacturer's criteria, (ii) those testing positive for the E target, but negative for the ORF-1ab target with the RT-PCR cobas® SARS-CoV-2 assay, according to the manufacturer's criteria, and (iii) those unresolved after the discrepant analytical testing.

c

The two SARS-CoV-2-specific probes are labelled with the same fluorophore, so the test provides a unique Ct value for both RdRP and N targets.

d

Specimens unavailable for discrepant analytical testing.

A minor disagreement is considered that discrepancy testing positive with one assay but inconclusive with the other study technique. Contrary, a major disagreement is considered that reverting from positive to negative depending on the study assay.

Abbreviations: TMA: transcription-mediated amplification; RT-PCR: real-time reverse-transcriptase PCR; Ct: cycle-threshold; P: positive; N: negative; I: inconclusive; NA: not amplified; ND: not determined.